Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CLGNNASDAQ:NXLNASDAQ:PYPDOTCMKTS:YBGJ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLGNCollPlant Biotechnologies$2.12-4.1%$2.77$2.00▼$6.75$24.29M1.3211,249 shs13,007 shsNXLNexalin Technology$1.82$2.05$0.53▼$4.49$24.26M4.61.24 million shs21,643 shsPYPDPolyPid$2.85+8.8%$2.77$2.30▼$5.09$29.04M1.2814,610 shs70,408 shsYBGJYubo International Biotech$0.08+13.9%$0.06$0.03▼$1.37$9.79M3.6611,714 shs8,000 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLGNCollPlant Biotechnologies-7.42%+6.00%-17.83%-43.01%-63.95%NXLNexalin Technology0.00%+4.00%-6.67%-36.81%+18.95%PYPDPolyPid+8.78%+4.01%+5.17%-4.68%-40.28%YBGJYubo International Biotech+13.95%+61.78%+65.38%+80.75%-76.57%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCLGNCollPlant Biotechnologies2.3924 of 5 stars3.73.00.00.01.90.01.3NXLNexalin Technology2.4922 of 5 stars3.53.00.00.01.93.30.0PYPDPolyPid2.1399 of 5 stars3.63.00.00.01.91.70.0YBGJYubo International BiotechN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLGNCollPlant Biotechnologies 3.33Buy$12.50489.62% UpsideNXLNexalin Technology 3.00Buy$5.00174.73% UpsidePYPDPolyPid 3.25Buy$11.33297.66% UpsideYBGJYubo International Biotech 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest YBGJ, PYPD, CLGN, and NXL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/14/2025PYPDPolyPidHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$11.00 ➝ $11.003/27/2025CLGNCollPlant BiotechnologiesD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$14.00 ➝ $14.003/24/2025NXLNexalin TechnologyMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$5.002/12/2025CLGNCollPlant BiotechnologiesD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$14.00 ➝ $14.002/4/2025CLGNCollPlant BiotechnologiesD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$14.00 ➝ $14.00(Data available from 5/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLGNCollPlant Biotechnologies$515K47.15N/AN/A$2.47 per share0.86NXLNexalin Technology$168.72K143.77N/AN/A$0.43 per share4.23PYPDPolyPidN/AN/AN/AN/A$0.75 per shareN/AYBGJYubo International Biotech$610K16.05N/AN/A($0.02) per share-4.09Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLGNCollPlant Biotechnologies-$7.02M-$1.46N/AN/AN/A-2,680.00%-77.05%-61.43%5/27/2025 (Estimated)NXLNexalin Technology-$4.65M-$0.82N/A∞N/A-3,407.98%-187.59%-167.21%5/9/2025 (Estimated)PYPDPolyPid-$29.02M-$4.97N/A∞N/AN/A-624.10%-129.28%5/6/2025 (Estimated)YBGJYubo International Biotech-$1.20M-$0.01N/A∞N/AN/AN/A-121.41%N/ALatest YBGJ, PYPD, CLGN, and NXL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025PYPDPolyPid-$0.74N/AN/AN/AN/AN/A3/26/2025Q4 2024CLGNCollPlant Biotechnologies-$0.42-$0.34+$0.08-$0.34$0.36 million$0.17 million3/14/2025Q4 2024NXLNexalin TechnologyN/A-$0.28N/A-$0.28N/A$0.03 million2/12/2025Q4 2024PYPDPolyPid-$0.90-$1.13-$0.23-$1.13N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCLGNCollPlant BiotechnologiesN/AN/AN/AN/AN/ANXLNexalin TechnologyN/AN/AN/AN/AN/APYPDPolyPidN/AN/AN/AN/AN/AYBGJYubo International BiotechN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLGNCollPlant BiotechnologiesN/A5.385.23NXLNexalin TechnologyN/A16.4215.89PYPDPolyPid0.081.311.00YBGJYubo International BiotechN/A0.160.16Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLGNCollPlant Biotechnologies21.69%NXLNexalin Technology0.65%PYPDPolyPid26.47%YBGJYubo International BiotechN/AInsider OwnershipCompanyInsider OwnershipCLGNCollPlant Biotechnologies9.60%NXLNexalin Technology24.00%PYPDPolyPid24.70%YBGJYubo International Biotech56.48%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLGNCollPlant Biotechnologies7011.46 million10.36 millionOptionableNXLNexalin Technology313.33 million10.11 millionNot OptionablePYPDPolyPid8010.19 million7.67 millionNo DataYBGJYubo International Biotech20119.82 million52.15 millionNot OptionableYBGJ, PYPD, CLGN, and NXL HeadlinesRecent News About These CompaniesYubo International Biotech Limited (YBGJ)March 21, 2025 | finance.yahoo.comYubo International Biotech LimitedNovember 21, 2024 | investing.comYBGJ Yubo International Biotech LimitedMay 25, 2024 | seekingalpha.comForever Cheer picks Hong Kong as gateway for global launch of pain management drugs with an eye on US$88.2 billion marketJanuary 3, 2024 | scmp.comPromontory Therapeutics Selected as the First International Biotech Company Member of the Paris-Saclay Cancer ClusterOctober 1, 2023 | finance.yahoo.comSABAH OFFERS TREASURE TROVE OF GENETIC RESOURCES FOR BIOTECH - MINISTERSeptember 10, 2023 | bernama.comAs biotech conference arrives in Boston, Wu launches push to diversify industryJuly 6, 2023 | wgbh.orgYubo International Biotech Ltd.June 15, 2023 | wsj.comChemical Engineering (Biotechnology) MEApril 20, 2023 | buffalo.eduBiotechnology – A Solution to Hunger?February 12, 2023 | un.orgCovid-19: Bharat Biotech to launch intranasal vaccine on January 26January 23, 2023 | scroll.inGLOBAL TOTAL REWARDS AND INTERNATIONAL MOBILITY HEADDecember 25, 2022 | mypharma-editions.comBiology newsSeptember 14, 2022 | phys.orgBiotechnology Act to Crash Cost of Vaccines, Drugs Import, Drive ResearchSeptember 12, 2022 | thisdaylive.comYubo International (OTC:YBGJ), Earnings Estimates, EPS, and RevenueJuly 18, 2022 | benzinga.comYubo International (OTC:YBGJ), Analyst Ratings, Price Targets, PredictionsJuly 18, 2022 | benzinga.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeYBGJ, PYPD, CLGN, and NXL Company DescriptionsCollPlant Biotechnologies NASDAQ:CLGN$2.12 -0.09 (-4.07%) As of 04/30/2025 03:59 PM EasternCollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; as well as develops injectable breast implants and 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures. It has collaboration agreements with Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; International Society for Biofabrication; AbbVie; and STEMCELL Technologies. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. The company was founded in 2004 and is headquartered in Rehovot, Israel.Nexalin Technology NASDAQ:NXL$1.82 0.00 (0.00%) As of 04/30/2025 04:00 PM EasternNexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.PolyPid NASDAQ:PYPD$2.85 +0.23 (+8.78%) As of 04/30/2025 03:56 PM EasternPolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.Yubo International Biotech OTCMKTS:YBGJ$0.08 +0.01 (+13.95%) As of 04/30/2025 03:46 PM EasternYubo International Biotech Limited, through its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is headquartered in Beijing, China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Hims & Hers Stock Soars on Novo Nordisk Collaboration 3 Dividend Kings Outshining the Market in 2025 Tesla's Band-Aid Has Been Ripped Off: Rally Mode Engaged Amazon's Earnings Will Make or Break the Stock's Comeback Why D-Wave's Project With Davidson Is a Game-Changer For Quantum NXP Semiconductors: A Buy-and-Hold Stock in the Buy Zone Joby Aviation Shares Eye Breakout After Transition Flight Win Altria’s Resilient Strategy Keeps It a Top Dividend Play in 2025 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
